ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Basic Aromatherapy to Help Balance and Calm

Tea drinkers have lower glaucoma risk

Soy, cruciferous vegetables could help lower breast cancer treatment side effects

The Long-Term Benefits of Drinking Oolong Tea

Why You Should Try This Sweet-Smelling and Health-Boosting Essential Oil

Wonderful White Tea: A Drink Fit for an Emperor

Arnica: This Powerful Herb Promotes Various Kinds of Healing

Chamomile Tea: Why This Ancient Therapeutic Drink Still Stands Out Today

Get ‘Hooked’ on Cat’s Claw: The Many Benefits of This Amazonian Herb

Try Apple Cider Vinegar and Black Cumin Oil as Your Go-To Salad Dressing

Print Page
Email Article

Roche Cancer Drug Trial Succeeds Two Years Early

  [ 177 votes ]   [ Discuss This Article ] • April 14, 2004

ZURICH, April 13 (Reuters) - A late-stage clinical trial of cancer drug MabThera for treating the relapsed indolent form of non-Hodgkin's lymphoma met its primary goals two years earlier than expected, Roche Holding AG (ROG.VX) said on Tuesday. MabThera, also known as Rituxan, is already the Swiss healthcare group's top-selling drug. Genentech Inc (NYSE:DNA - News) and Biogen Idec (NasdaqNM:BIIB - News) co-market MabThera in the United States.

In the two-part phase III trial, patients were randomly assigned to get MabThera plus chemotherapy or chemotherapy alone as initial treatment, and responding patients received MabThera for two years as maintenance therapy or no further treatment. Analysis showed that "MabThera plus chemotherapy was significantly more effective than chemotherapy alone as initial treatment, and patients subsequently treated with MabThera maintenance for two years had significantly better progression-free survival than those who received no further treatment", a Roche statement said.

Roche's drug division chief, William Burns, noted that more than half of patients with relapsed indolent NHL are treated with chemotherapy alone at present and said the trial confirmed that MabThera should be the standard of care for patients with that form of the disease. An independent panel monitoring the trial data suggested changing the objective of the study to answer the question of whether MabThera maintenance therapy benefits patients receiving MabThera plus chemotherapy as initial treatment, so the trial will be amended in this way, Roche said.

Non-Hodgkin's lymphoma affects 1.5 million people worldwide. Indolent NHL, representing about 45 percent of NHL patients, is a slowly developing but serious cancer of the lymphatic system. MabThera is already indicated as a single-agent treatment for relapsed or refractory indolent NHL and received European approval in March 2002 for treating the aggressive form of NHL in combination with standard chemotherapy.

Post a Comment

Featured Products From the ProHealth Store
Optimized Curcumin Longvida® Vitamin D3 Extreme™ Energy NADH™ 12.5mg

Article Comments

Be the first to comment on this article!

Post a Comment

Optimized Curcumin Longvida with Omega-3

Featured Products

Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get Energized with Malic Acid & Magnesium
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health

Natural Remedies

Health Benefits Are Brewing in Green Tea Health Benefits Are Brewing in Green Tea
The New Dual Activation Pain Relief Cream The New Dual Activation Pain Relief Cream
The Revolutionary 'Good Fat' That Promotes Heart, Brain, Bone and Joint Health The Revolutionary 'Good Fat' That Promotes Heart, Brain, Bone and Joint Health
The Cellular Enzyme That Promotes Longevity And Reduces Fat Storage The Cellular Enzyme That Promotes Longevity And Reduces Fat Storage
How to Jump-start and Sustain Energy Production in CFS How to Jump-start and Sustain Energy Production in CFS

ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
Credit Card Processing
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2018 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map